Shares of IonQ sold off dramatically toward the end of 2025, and further selling pressure could be on the horizon.
Why Big Pharma Is Betting Billions To Beat A $170B Patent Cliff. Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 14, 2026 /PRNewswire/ -- Equity-Insider News Commentary – The precisio ...
Benton Receives Positive Metallurgical Results From South Pond With Gold Recoveries Up To 88.4%. Benton Receives Positive ...
Dante Moore rejecting the NFL Draft sounds like bad news for Dylan Raiola, who was set to take over at Oregon. But sitting a ...
Myqorzo and Redemplo approved in China Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndromeUnderscores Sanofi's long-term commitment to ...